| |
| |
|
| Insider
Information: |
Chalmers Derek T |
| Relationship: |
President & CEO, Direc... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,362,072 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$37,861,273 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,362,072 |
|
|
| Total
Value |
$37,861,273 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -39.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Arena Pharmaceuticals Inc |
ARNA |
Former VP, Research an... |
2004-06-11 |
370,667 |
2004-06-11 |
0 |
Premium* |
|
|
Cara Therapeutics, Inc. |
CARA |
President & CEO, Direc... |
2021-09-07 |
991,405 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
59 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARNA |
Arena Pharmaceuticals Inc |
Former VP, Research and Dir. |
– – – |
2004-06-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(45,833) |
370,667 |
|
- |
|
| CARA |
Cara Therapeutics, Inc. |
President & CEO |
• • – |
2020-01-02 |
4 |
AS |
$16.05 |
$160,500 |
D/D |
(10,000) |
917,769 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
President & CEO |
• • – |
2019-12-02 |
4 |
AS |
$25.79 |
$257,900 |
D/D |
(10,000) |
918,468 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
President & CEO |
• • – |
2019-12-04 |
4 |
AS |
$17.05 |
$182,418 |
D/D |
(10,699) |
927,769 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
President & CEO |
• • – |
2019-11-01 |
4 |
AS |
$20.79 |
$103,950 |
D/D |
(5,000) |
928,468 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
President & CEO |
• • – |
2020-12-16 |
4 |
S |
$14.95 |
$74,750 |
D/D |
(5,000) |
928,921 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
President & CEO |
• • – |
2019-10-01 |
4 |
AS |
$18.28 |
$182,800 |
D/D |
(10,000) |
933,468 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
President & CEO |
• • – |
2020-12-10 |
4 |
S |
$15.29 |
$114,675 |
D/D |
(7,500) |
933,921 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
President & CEO |
• • – |
2020-12-30 |
4 |
AS |
$15.30 |
$92,993 |
D/D |
(6,078) |
936,593 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
President & CEO |
• • – |
2019-12-02 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
938,468 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
President & CEO |
• • – |
2020-11-17 |
4 |
AS |
$16.00 |
$188,784 |
D/D |
(11,799) |
941,421 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
President & CEO |
• • – |
2020-12-28 |
4 |
AS |
$16.00 |
$80,000 |
D/D |
(5,000) |
942,671 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
President & CEO |
• • – |
2019-09-03 |
4 |
AS |
$23.26 |
$116,300 |
D/D |
(5,000) |
943,468 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
President & CEO |
• • – |
2021-02-25 |
4 |
AS |
$19.33 |
$226,722 |
D/D |
(11,729) |
943,614 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
President & CEO |
• • – |
2019-03-01 |
4 |
AS |
$17.04 |
$166,856 |
D/D |
(9,792) |
943,996 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
President & CEO |
• • – |
2020-12-23 |
4 |
A |
$0.00 |
$0 |
D/D |
18,750 |
947,671 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
President & CEO |
• • – |
2019-08-01 |
4 |
AS |
$23.27 |
$232,700 |
D/D |
(10,000) |
948,468 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
President & CEO |
• • – |
2021-03-05 |
4 |
AS |
$17.98 |
$55,792 |
D/D |
(3,103) |
950,511 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
President & CEO |
• • – |
2020-09-03 |
4 |
AS |
$16.00 |
$51,216 |
D/D |
(3,201) |
953,220 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
President & CEO |
• • – |
2021-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
953,614 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
President & CEO |
• • – |
2019-02-01 |
4 |
AS |
$14.99 |
$299,800 |
D/D |
(20,000) |
953,788 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
President & CEO |
• • – |
2021-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
18,750 |
955,343 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
President & CEO |
• • – |
2020-08-03 |
4 |
AS |
$16.42 |
$82,100 |
D/D |
(5,000) |
956,421 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
President & CEO |
• • – |
2019-05-29 |
4 |
AS |
$21.42 |
$118,410 |
D/D |
(5,528) |
958,468 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
President & CEO |
• • – |
2020-07-01 |
4 |
AS |
$17.11 |
$85,550 |
D/D |
(5,000) |
961,421 |
0 |
% |
|
59 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
